Tegal Corporation Closes Acquisition of CollabRx, Inc. and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Published: Jul 16, 2012

PETALUMA, Calif.--(BUSINESS WIRE)--Tegal Corporation (NASDAQ: TGAL) today announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine.

Back to news